Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RA Capital Nexus Fund II
Wilmington, Delaware, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
RA Capital Nexus Fund II is a $461M closed‑ended venture fund managed by RA Capital Management to invest alongside its other accounts in private biotech and healthcare companies, expanding RA Capital’s private deal capacity and enabling larger positions in high‑conviction life science investments.[1][3][5]
- Industry
- Investors
Beyond the preview
Go deeper on RA Capital Nexus Fund II.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RA Capital Nexus Fund II.